Nevanac Ophthalmic Drops, Suspension 0.1pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Nevanac: Ophthalmic drops, suspension (0.1%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Nevanac 0.1% Ophth Susp

What is this Medicine?

NEPAFENAC (ne paf FEN ak) is a non-steroidal anti-inflammatory drug (NSAID). The eye drops are used to treat pain and swelling after eye surgery.

CVS Pharmacy Patient Statistics for Nevanac: Ophthalmic drops, suspension(0.1%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Nevanac 0.1% Ophthalmic Suspension

NDC: 000650002
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Postoperative Ocular Inflammation, Ocular Pain

Storage Information
Store between 36 to 77 degrees F
Nevanac 0.1% Ophthalmic Suspension

Reported Side Effects for Nevanac 0.1% Ophthalmic Suspension

Headache Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
1.0-4.0%*
Severity: MODERATE
Onset: EARLY
Sinus Infection Incidence:
1.0-4.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Nevanac

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5